Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Bremerton
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Bremerton, WA

Studies commonly pay $75 to $4,500 per completed study

1,467 clinical trials are currently recruiting participants within 30 miles of Bremerton. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,467studies recruiting
9+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Bremerton right now

Top 25 of 1,467 recruiting studies, sorted by proximity — each links to its official registry page

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

High Grade Glioma, Diffuse Intrinsic Pontine Glioma Phase 2 Interventional 120 participants sought
Seattle Children's Hospital — Seattle, Washington (18.2 mi) · Sponsor: Nationwide Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT05096481)

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia Phase 1 Interventional 40 participants sought
Washington Center for Bleeding Disorders — Seattle, Washington (18.2 mi) · Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
See eligibility & contact on ClinicalTrials.gov (NCT05500807)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Seattle Children's Hospital — Seattle, Washington (18.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Solid Tumor, Adult, Metastatic Breast Cancer Phase 1 Interventional 392 participants sought
Fred Hutchinson Cancer Center — Seattle, Washington (18.2 mi) · Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See eligibility & contact on ClinicalTrials.gov (NCT06625775)

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus N/A Interventional 400 participants sought
Seattle Children's — Seattle, Washington (18.2 mi) · Sponsor: Medtronic MiniMed, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07228117)

ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

Dravet Syndrome Phase 1, Phase 2 Interventional 32 participants sought
Seattle Children's Hospital — Seattle, Washington (18.2 mi) · Sponsor: Ionis Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07531745)

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
Northwest Medical Specialties — Gig Harbor, Washington (16.0 mi) · Sponsor: American Society of Clinical Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02693535)

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Follicular Lymphoma, Marginal Zone Lymphoma Phase 1, Phase 2 Interventional 80 participants sought
University of Washington-Seattle Cancer Care Alliance — Seattle, Washington (18.2 mi) · Sponsor: Enterome
See eligibility & contact on ClinicalTrials.gov (NCT04669171)

ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA

Abdominal Aortic Aneurysms N/A Observational 200 participants sought
University of Washington — Seattle, Washington (18.2 mi) · Sponsor: ViTAA Medical Solutions
See eligibility & contact on ClinicalTrials.gov (NCT05004051)

A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)

Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2 Phase 1, Phase 2 Interventional 10 participants sought
University of Washington Medical Center — Seattle, Washington (18.2 mi) · Sponsor: AskBio Inc
See eligibility & contact on ClinicalTrials.gov (NCT05230459)

Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants

Prematurity, Iron-deficiency Phase 2 Interventional 120 participants sought
University of Washington — Seattle, Washington (18.2 mi) · Sponsor: University of Washington
See eligibility & contact on ClinicalTrials.gov (NCT05340465)

Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial

Crohn Disease N/A Interventional 60 participants sought
Seattle Children's Hospital — Seattle, Washington (18.2 mi) · Sponsor: Seattle Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT06216899)

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

Retinoblastoma Bilateral, Retinoblastoma Unilateral N/A Observational 100 participants sought
University of Washington — Seattle, Washington (18.2 mi) · Sponsor: University of Washington
See eligibility & contact on ClinicalTrials.gov (NCT06725173)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Seattle, Washington (18.2 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies

Hematopoietic and Lymphatic System Neoplasm N/A Interventional 40 participants sought
Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington (18.2 mi) · Sponsor: Fred Hutchinson Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT04829136)

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma Phase 2 Interventional 81 participants sought
Fred Hutchinson Cancer Center — Seattle, Washington (18.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05112601)

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Tacoma, Washington (23.7 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06129864)

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG Phase 2 Interventional 60 participants sought
Seattle Children's Hospital — Seattle, Washington (18.2 mi) · Sponsor: Nationwide Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT06838676)

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Phase 4 Interventional 787 participants sought
Swedish Cancer Institute — Seattle, Washington (18.2 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06876649)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Seattle, Washington (18.2 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Saint Michael Cancer Center — Silverdale, Washington (7.0 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Papillary Thyroid Cancer, Pediatric Cancer N/A Observational 32 participants sought
Seattle Children's Hospital — Seattle, Washington (18.2 mi) · Sponsor: Children's Hospital of Philadelphia
See eligibility & contact on ClinicalTrials.gov (NCT05024929)
Actively enrolling

Studies you may be able to join near Bremerton

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for cirrhosis caused by MASH

Enrolling adults aged 18 to 80 with a physician diagnosis of liver cirrhosis caused by MASH (metabolic dysfunction-associated steatohepatitis). Not open to people with treated ascites, variceal bleeding, hepatitis B or C, or alcohol-related liver disease.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Bremerton

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Northwest Clinical Research Center

★ 3.9
1951 152nd Pl NE #200, Bellevue, WA 98007
(425) 453-0404
"Great staff and awesome research studies."
— Linda Martinez, 5★

Sound Medical Research

463 Tremont St W #200, Port Orchard, WA 98366
(360) 329-5220

Seattle Clinical Research Center

★ 5.0
633 Yesler Wy, Seattle, WA 98104
(206) 522-3330
"I have been part of a vaccine trial here and the staff are so kind. I have a lot of medical anxiety due to some poor experiences. Typically, being in…"
— Kamla Anand Corder, 5★

Rainier Clinical Research Center

★ 4.3
800 SW 39th St Ste 110, Renton, WA 98057
(425) 251-1720
"I have been participating in Type 1 Diabetes studies at Rainier Clinical for at least 15 years and until recently have been impressed with the manage…"
— Annalise k, 3★

Clinical Research Center at Minor

★ 4.7
820 Minor Ave N, Seattle, WA 98109
(206) 667-7100
"Wonderful staff, supportive environment"
— Susan Mausshardt, 5★

DM Clinical Research — Seattle

★ 4.9
600 Broadway, Seattle, WA 98122
(425) 399-8006
"Very professional. Very nice they furnish u er ride when needed"
— Gretchen Schmidt, 4★

Harborview Research and Training Building

★ 4.8
300 9th Ave, Seattle, WA 98104
(206) 744-3000
"Clean and the staff was very nice and professional and happy to help the doctors where amazing people Five star's ✨"
— Crystal Boles, 5★

Seattle Institute for Biomedical and Clinical Research (SIBCR)

★ 2.3
1325 4th Ave Ste 1310, Seattle, WA 98101
(206) 204-9030
"These guys just changed our top tier insurance to one of the worst insurances, especially the dental. Goodbye boutique dentists. Hello brightnow dent…"
— Justin Cook, 1★

Swedish Center for Research and Innovation

800 5th Ave 11th Fl, Seattle, WA 98104
(206) 215-3100

Clinical trials in Bremerton: what's recruiting

The Bremerton area currently has 1,467 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Bremerton, the most active research areas are:

  • Cancer & Oncology15 studies
  • Diabetes & Metabolism1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Bremerton, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Bremerton

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Bremerton participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Bremerton pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Bremerton?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Bremerton safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Bremerton, WA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Bremerton typically complete one or two studies per year.

Paid clinical trials near Bremerton

Other metros within reach

Seattle, WA1,492 Tacoma, WA1,445 Olympia, WA224 Bellevue, WA1,500 Marysville, WA199 Vancouver, WA1,016 Portland, OR1,016 Salem, OR111

By condition

Eligibility and exclusions, condition by condition

MASH (cirrhosis due to MASH) in Bremerton Bladder Issues Due To Spinal Cord Injury in Bremerton All conditions

More of WA

Bellevue1,500 Seattle1,492 Tacoma1,445 Vancouver1,016 Spokane293 Olympia224 Marysville199 Kennewick54

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts